KO

KOREA PHARMA Co., Ltd.

Develops and produces prescription medicines with a focus on Central Nervous System drugs.

032300 | KO

Overview

Corporate Details

ISIN(s):
KR7032300006
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단3길 87, 화성시

Description

KOREA PHARMA Co., Ltd. is a pharmaceutical company established in 1974 that specializes in the development and production of prescription-based medicines. The company has a particular focus on drugs for the Central Nervous System (CNS). Its product portfolio covers a wide range of therapeutic areas, including hepatic, gastrointestinal, antimicrobial, and antihistamine drugs. The company also offers treatments such as amino acids, antibiotics, antidotes, and antiepileptics, aiming to improve and maintain public health through its specialized pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-07 00:00
주식등의대량보유상황보고서(일반)
Korean 127.8 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-14 00:00
주식등의대량보유상황보고서(일반)
Korean 137.1 KB
2025-04-01 00:00
합병등종료보고서(자산양수도)
Korean 14.9 KB
2025-03-28 00:00
정기주주총회결과
Korean 30.2 KB
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.5 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 572.5 KB
2025-03-14 00:00
감사보고서제출
Korean 18.5 KB
2025-03-12 00:00
주주총회소집결의
Korean 18.9 KB
2025-03-12 00:00
주주총회소집공고
Korean 103.6 KB
2025-03-12 00:00
주주총회집중일개최사유신고
Korean 4.3 KB
2025-03-07 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-03-07 00:00
현금ㆍ현물배당결정
Korean 8.5 KB
2025-02-07 00:00
주식등의대량보유상황보고서(일반)
Korean 124.9 KB

Automate Your Workflow. Get a real-time feed of all KOREA PHARMA Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREA PHARMA Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREA PHARMA Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.